Takeda Pharmaceutical Company Limited (TAK) Financials

TAK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 97.2 billion 48.3 billion
Dec. 31, 2025 98.4 billion 49.6 billion
Sept. 30, 2025 97.8 billion 49.6 billion
June 30, 2025 97.4 billion 49.6 billion

TAK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -162.9 million ?
Dec. 31, 2025 2.0 billion 113.6 million
Sept. 30, 2025 2.2 billion 126.6 million
June 30, 2025 976.0 million 115.0 million

TAK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -155.0 million
Dec. 31, 2025 673.5 million
Sept. 30, 2025 -79.2 million
June 30, 2025 864.2 million

TAK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.7 billion 27.5 billion -
Dec. 31, 2025 4.9 billion 27.3 billion -
Sept. 30, 2025 5.0 billion 29.4 billion -
June 30, 2025 2.9 billion 28.8 billion -

TAK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 20.5 million
Sept. 30, 2025 21.3 million
June 30, 2025 22.1 million

TAK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 285.9 million 1.2 billion 1.9 billion -
Dec. 31, 2025 271.7 million 1.1 billion 1.8 billion -
Sept. 30, 2025 356.9 million 1.1 billion 1.7 billion -
June 30, 2025 522.0 million 1.0 billion 1.8 billion -

TAK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 7.0 billion 3.6 billion
Dec. 31, 2025 7.7 billion 3.5 billion
Sept. 30, 2025 7.5 billion 2.6 billion
June 30, 2025 7.7 billion 2.7 billion

TAK

Price: $15.60

52 week price:
12.99
18.90

Dividend Yield: 4.01%

5-year range yield:
3.76%
5.08%

Forward Dividend Yield: 4.17%

Payout Ratio: 177.09%

Payout Ratio Range:
-1840.96%
1893.98%

Dividend Per Share: 0.64 USD

Earnings Per Share: 0.38 USD

P/E Ratio: 43.63

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Japan

Volume: 2.3 million

Market Capitalization: 48.9 billion

Average Dividend Frequency: 2

Years Paying Dividends: 18

DGR3: 0.19%

DGR5: -4.55%

DGR10: -6.07%

Links: